Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Ketamine Infusion for Symptomatic Improvement in Severe Borderline Personality Disorder: A Pilot Study

NCT07099534 is registered in ClinicalTrials.gov with University Hospital, Toulouse as lead sponsor.

NCT NCT07099534
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07099534 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Ketamine Infusion for Symptomatic Improvement in Severe Borderline Personality Disorder: A Pilot Study
Lead sponsor
University Hospital, Toulouse
Phase
Phase 2
Overall status
Not yet recruiting
Start date
September 1, 2026
Completion date
September 30, 2028
Enrollment
38 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

borderline personality disorder (bpd), infusion of ketamine in severe borderline personality disorder